Taken together, all these data suggested a pivotal role of CELF2 in HCC tumorigenesis, migration, and chemoresistance, and we provided evidence that CELF2 silencing in HCC cell line 1 reversed the inhibiting effect of shCRNDE on cell viability, invasion, and migration. The gene discussed is CELF2; the disease is hepatocellular carcinoma.